The "Global Anti-obesity Drugs Market 2021-2025" report has been added to ResearchAndMarkets.com's offering.
Global Anti-obesity Drugs Market 2021-2025
The anti-obesity drugs market is poised to grow by $ 454.51 mn during 2021-2025 decelerate at a CAGR of 5% during the forecast period.
The market is driven by the limited number of approved drugs and use of bariatric surgery limited for morbid obesity.
The reports on anti-obesity drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The anti-obesity drugs market analysis includes type segment and geographical landscapes.
This study identifies the growing obese population as one of the prime reasons driving the anti-obesity drugs market growth during the next few years.
The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading anti-obesity drugs market vendors that include Bausch Health Companies Inc., Currax Pharmaceuticals LLC, F. Hoffmann-La Roche Ltd., Gelesis Inc., GlaxoSmithKline Plc, Novo Nordisk AS, RECORDATI S.p.A., Rhythm Pharmaceuticals, Inc., Teva Pharmaceutical Industries Ltd., and VIVUS Inc..
Also, the anti-obesity drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Key Topics Covered:
Value chain analysis
Market segment analysis
Market size 2020
Market outlook: Forecast for 2020 - 2025
Five Forces Analysis
Five Forces Summary
Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market Segmentation by Type
Comparison by Type
Class III anti-obesity drugs - Market size and forecast 2020-2025
Class II anti-obesity drugs - Market size and forecast 2020-2025
Class I anti-obesity drugs - Market size and forecast 2020-2025
Market opportunity by Type
Market segmentation by Mechanism of Action
Centrally acting anti-obesity drugs
Peripherally acting anti-obesity drugs
Other anti-obesity drugs
North America - Market size and forecast 2020-2025
Europe - Market size and forecast 2020-2025
Asia - Market size and forecast 2020-2025
ROW - Market size and forecast 2020-2025
Key leading countries
Market opportunity by geography
Market positioning of vendors
Bausch Health Companies Inc.
Currax Pharmaceuticals LLC
F. Hoffmann-La Roche Ltd.
Novo Nordisk AS
Teva Pharmaceutical Industries Ltd.
For more information about this report visit https://www.researchandmarkets.com/r/d3o1gr
View source version on businesswire.com: https://www.businesswire.com/news/home/20210413006031/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900